Empreendimentos Pague Menos (PGMN3) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Achieved record profitability in 2Q26, with EBITDA margin at 6.5% and net income up 22.2% year-over-year, driven by operational leverage, disciplined expense control, and strategic advances.
Same-store sales grew 8.0%, outpacing inflation by 3x, and market share reached 6.7% nationally, with gains in all regions for the 11th consecutive quarter.
Digital channel sales exceeded R$1 billion, up 40.6% year-over-year, now representing 24.1% of total sales.
Recognized as one of the top 10 retail companies to work for in Brazil, emphasizing a people-centric culture and community engagement.
Active client base reached 22.6 million, driven by growth in Continuous Care Clients.
Financial highlights
Gross revenue grew 9.3% year-over-year in Q2 2026 to R$4.34 billion, with a three-year CAGR of 14%.
Adjusted EBITDA rose 15.4% to R$281.7 million, with margin at 6.5%.
Net income increased 22.2% to R$73.6 million, with EPS at R$0.51.
Operating cash flow tripled to R$188.8 million in Q2, with LTM operating cash flow at R$573.4 million.
Net debt/EBITDA improved to 1.8x, marking the twelfth consecutive quarter of deleveraging.
Outlook and guidance
Store openings expected to accelerate as deleveraging continues, with investments in logistics and technology supporting future growth.
Expecting normalization of gross margin pressures and inventory build-up by end of 3Q26 as the new Paraíba distribution center gains efficiency.
Strategic focus on market share growth, private label expansion, and continued digital channel improvements.
Latest events from Empreendimentos Pague Menos
- Revenue and profit surged as growth accelerated, cash flow improved, and market share increased.PGMN3
Q2 202415 Jul 2026 - Record sales, margin gains, and cash flow driven by Extrafarma synergies and digital growth.PGMN3
Q3 202415 Jul 2026 - Record revenue, EBITDA, and digital sales drove margin gains and market share growth in 1Q25.PGMN3
Q1 202515 Jul 2026 - Record sales and digital growth drove higher margins, profit, and market share gains.PGMN3
Q2 202515 Jul 2026 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202515 Jul 2026 - Revenue up 14.4% YoY, net income quadrupled, and digital sales surged to 22.2% of total.PGMN3
Q1 202615 Jul 2026 - 2025 saw record revenue, EBITDA, and net income, with market share and digital sales at all-time highs.PGMN3
Q4 20257 Jul 2026 - Record sales, margin expansion, and synergy gains drive robust growth and deleveraging.PGMN3
Q4 20242 Jul 2026 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025